Zhen-Wu-Tang ameliorates uremic cardiomyopathy via targeting the kidney–heart inflammatory axis and suppressing CCL2/CCR2-mediated macrophage activation
Abstract
ZWT exerts therapeutic effects on UC by targeting the kidney-heart inflammatory axis and suppressing CCL2/CCR2-mediated macrophage activation. This study provides new insights into the molecular mechanisms underlying ZWT's efficacy in treating heart-kidney disorders.
What are the key findings of this study?
Zhen-Wu-Tang is a treatment that helps improve heart problems caused by kidney issues. It works by reducing inflammation and stopping certain immune cells from becoming too active. This matters because it could lead to better ways to treat heart-kidney disorders and improve overall health. 💖
Key Points
Objective
To explore the therapeutic effects of Zhen-Wu-Tang on uremic cardiomyopathy by investigating its impact on kidney-heart inflammation.
Methods
- Examined the effects of Zhen-Wu-Tang on inflammatory pathways in uremic cardiomyopathy.
- Focused on CCL2/CCR2 signaling and macrophage activation.
- Used molecular analyses to understand therapeutic mechanisms.
Results
- Zhen-Wu-Tang significantly reduced inflammation in the kidney-heart axis.
- Suppressed CCL2/CCR2-mediated macrophage activation was observed.
- Improved cardiac function metrics were noted in treated models.
What is the clinical evidence from this study?
Study Design
Other
Population
Uremic cardiomyopathy
Intervention
Zhen-Wu-Tang (ZWT) vs. Sham, Vehicle (UC model), Captopril (9.75 mg/kg/d), Finerenone (10 mg/kg/d)
Key Finding
Zhen-Wu-Tang significantly ameliorated renal and cardiac dysfunction in uremic cardiomyopathy mice by suppressing CCL2/CCR2-mediated macrophage activation.
Limitations
- In vitro models cannot fully recapitulate the systemic complexity of the cardio-renal axis in vivo.
- Large-scale randomized controlled trials are needed to validate the long-term clinical efficacy of ZWT.
- Detailed systemic pharmacokinetics and tissue-specific pharmacodynamics remain to be fully elucidated.
- CCL2 overexpression and targeted NF-κB inhibition strategies are warranted to further substantiate the necessity of the NF-κB–CCL2 axis.